*Influencers received 50 units in 3 areas.
What is Xeomin?
Xeomin is a newer, purer type of botulin tox wrinkle relaxing injection. As one of the top Xeomin, the alternative botulin tox, injecting medspas in the USA, we've revolutionized the industry with our injection skills and value. For example:
For $99, get 20 units of the alternative Botulin Tox, Xeomin® for one area
Over 50% off original price (
10 Minute Appointment
Results in 3-7 Days
Results typically last up to 3 Months
Don't just take our word for it!
Patients are raving about Xeomin!
If you are nervous about injecting your face, then we understand. We hear it all the time: "Don't make me look fake." We know that you just want to get back that bright, youthful look.
We've injected hundreds of thousands of units of Xeomin, so you are in expert hands. Your treatment will be personalized based on what you tell us.
Our philosophy is LESS IS MORE, especially if you are trying something new for the first time. We guarantee that your wrinkles will diminish after one week.
After your thorough consultation, you can apply a numbing cream. You will get micro injections on your face that can take less than 30 seconds to complete.
Will it hurt? Most of our patients describe it as a tolerable prickling sensation and some feel no discomfort at all. After the procedure, you can go back to work or take care of your errands without any downtime.
Frequently Asked Questions Xeomin
Xeomin is a purer form of botulinum toxin. Xeomin® was FDA-approved in 2011. Other types of FDA approved botulinum toxin includes Botox, Dysport and Jeuveau.
Xeomin® is among a class of medication called botuinum toxin. There are at least 5 different FDA approved neurotoxins available in the USA.
In research studies, Xeomin had a faster onset and a longer duration of wrinkle reduction than other botulinum toxin. Also, Xeomin's safety profile is similar to that of other botulinum toxins.
Most patients will see the full effect in 3 – 7 days. The effects may last up to 3 months.
You will get 20 units of Xeomin for $99. Each additional unit is $4.95/unit.
*You must activate XperienceMerz.com, which gives you a discount of $50 to receive this final pricing of $4.95/unit.
Park Medspa is offering this introductory offer to aesthetic influencers at an amazing price to try Xeomin for the first time. In order to qualify, you must not have had Xeomin in the past 90 days, pass medical screening questions and sign waiver and consent forms.
All Medical Professional injectors are physicians, nurse practitioners or physician assistants with extensive experience.
You are charged $4.95/unit for the touch up, if we are still offering this promotion.
Various symptoms such as asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties have been observed from hours to weeks following the injection.
There have been reports of death related to the spread of botulinum toxin from swallowing or breathing difficulties. You MUST seek immediate medical attention if swallowing, speech, or respiratory disorders occur.
Hypersensitivity reactions such as anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea have been reported. Any hypersensitivity to neurotoxin, human albumin, or sucrose can lead to life threatening anaphylaxis. If you experience any of the symptoms, then immediate medical attention is required.
Corneal exposure, ulceration, or ectropion has been reported. The loss of orbicularis muscle can lead to complications.
Xeomin also contains albumin, which is a derivative of human blood. Therefore, there is a theoretical risk of viral diseases, CJD, or vCJD, although none has ever been reported.
Xeomin is contraindicated in the following patients with known hypersensitivity to botulinum toxin or other components in the formulation or an infection at the site of injection.
Patients with peripheral motor neuropathy diseases, amyotrophic lateral sclerosis, or neuromuscular junctional disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) are at increased risk and cannot be injected.